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Abstract
Background: External quality assurance (EQA) programmes, which are routinely used in laboratories, have not been
widely implemented for point-of- care tests (POCTs). A study was performed in ten health centres in Tanzania, to
implement the use of dried blood spots (DBS) as an EQA method for HIV and syphilis (POCTs).
Method: DBS samples were collected for retesting at a reference laboratory and the results compared to the POCT
results obtained at the clinic. In total, 2341 DBS samples were collected from 10 rural health facilities over a period
of nine months, of which 92.5% were correctly collected and spotted.
Results: The EQA method was easily implemented by healthcare workers under routine conditions in Northern
Tanzania. For HIV, 967 out of 972 samples (99.5%) were concordant between DBS and POCT results. For syphilis,
the sensitivity of syphilis tests varied between clinics with a median of 96% (25th and 75th quartile; 95-98%). The
specificity of syphilis POCT was consistent compared to laboratory based test using DBS, with a median of 96%
(25th and 75th quartiles; 95-98%).
Conclusion: Overall, the quality of testing varied at clinics and EQA results can be used to identify clinics where
healthcare workers require remedial training, suggesting the necessity for stringent quality assurance programmes
for POC testing. As Tanzania embarks on scaling up HIV and syphilis testing, DBS can be a useful and robust tool
to monitor the quality of testing performed by healthcare workers and trigger corrective action to ensure
accuracy of test results.
Background
Point-of-care diagnostic tests (POCTs) are increasingly
used in both developing and developed countries [1].
They allow same day testing and treatment at remote
locations where no laboratory support is available.
Quality control measures, which are routinely used in
laboratories, have not been widely implemented for
POCTs. The World Health Organization and US Cen-
ters for Disease Control and Prevention advocates the
implementation of POCT with a quality assurance
method in place [2].
In Tanzania, the Ministry of Health currently recom-
mends the use of POCTs to screen pregnant women for
HIV and syphilis, but an External quality assurance (EQA)
method has not been implemented [3]. The use of DBS
for HIV testing has been evaluated, giving comparable
results to plasma [4]. Additionally, a laboratory based
evaluation using Tanzanian samples showed that DBS
TPPA gives comparable results to plasma [5]. Dried
blood spots (DBS) have been suggested as a potential
method for QA for HIV POCT [6], but this has not
been implemented under routine testing services.
In this study, we implemented DBS as an EQA method
for both HIV and syphilis POCT in Tanzania. The study
aims were; (1) to evaluate the feasibility of using DBS
as a continuous EQA method for end users in a rural
setting of a developing country; (2) To review the per-
formance of the various clinics involved in syphilis and
HIV testing; (3) to compare this EQA method with
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proficiency panels, and (4) to make the project’s protocols
available online.
Methods
Setting
As part of a larger study that implemented syphilis
POCT in seven developing countries, the Geita District
in Northern Tanzania was chosen for this study [3]. Ten
out of 51 antenatal care (ANC) clinics that participated
in the main study were selected based on location, type
of clinic, and willingness to participate. The study was
conducted in ten primary health clinics that offered
ANC and HIV voluntary counselling and testing (VCT)
services. To represent the various types of Tanzanian
clinics providing ANC and VCT services, the district
referral hospital, four health centres and five dispensaries
were included in this study. The classification of clinic
type is primarily based on the number of personnel and
which services are offered to the patients. The study
population were pregnant women and their partners.
The study was conducted over a period of nine months,
from January till September 2011.
Routine services offered
The EQA method was incorporated in the national
routine ANC and VCT services given at ANC clinics in
Tanzania. Patients accepting HIV and syphilis testing
were tested on-site using the SD Bioline syphilis 3.0
(Standard Diagnostics, Kyong gi-do, Korea) on whole
blood obtained by finger-prick. The national HIV POCT
testing algorithm consisted of SD Bioline HIV 3.0 (Standard
Diagnostics, Kyong gi-do, Korea), Determine HIV- 1/ HIV-2
(Abbott Laboratories,Wiesbaden-Delkenheim, Germany)
with Unigold (Trinity Biotech, Dublin, Ireland) as the tie-
breaker test. All tests used whole blood obtained by finger
prick and were performed according to the manufac-
turer’s recommendations. Free medical treatment was
provided to all patients testing positive for syphilis. HIV
positive patients were referred to Tanzanian care- and
treatment centres. All services were performed according
to Tanzanian guidelines.
Implementation of EQA method in routine practice
The patients were requested to donate blood for quality
control purposes and asked to provide oral consent by
the health care worker (HCW). Ethical approval was
obtained from ethical committees at the London School
of Hygiene and Tropical Medicine and at the National
Institute of Medical Research, NIMR, Tanzania. If consent
was given by the patient, whole blood was obtained by
finger prick according to standard protocols [2]. Whole
blood was applied to the POCT and the DBS was spotted
afterwards. The HCW was instructed to not perform
an additional finger-prick when the DBS could not be
completely filled, to minimize discomfort for the patient.
Only the POCT outcome, date of testing, patient number
and the clinic name were recorded on the study form.
At the start of the study, HCW that performed HIV
and syphilis testing received a one- day centralised training
for the collection of DBS samples. During the training,
HCW learned about the method and received hands-on
training of spotting blood onto filter paper, labelling
DBS samples, drying, and storing DBS samples. After
the training, HCW were given filter papers (Protein
Savercard 903, Whatman, GE healthcare, Wisconsin,
USA), desiccant bags (indicating desiccants, Brownell
ltd, UK), a dry rack (GE healthcare, Wisconsin, USA)
and ziplock bags (Minigrip, Netherlands) to store the
DBS samples. Syphilis POCT kits (SD Bioline syphilis
3.0, Standard Diagnostics, Kyong gi-do, Korea) were
purchased and transported to the hospital, from where
the kits were distributed to the clinics. To minimise the
workload, DBS samples were stored up to 10–15 cards
per ziplock bag with desiccants at the clinic. Risk of
cross contamination for serological testing was limited
due to the tucked cover of the DBS cards protecting
the blood spots.
To minimise the workload of the busy HCW, identifi-
cation stickers were used. One sticker was placed on the
DBS and the other on a registration form where the
matching POCT results could be encircled. Laboratory
technicians were masked to the POCT results and the
registration forms containing the POCT results were
entered into Epi-info v. 3.5.3 database (Centers for Disease
Control and Prevention, Atlanta, USA). Interviews were
conducted to obtain feedback of the HCW in June 2011.
All HCW found the method easy and relatively quick
to use. According to the HCW, the EQA process time
including spotting, labelling and recording result varied
from 2–6 minutes. As most HCW provided counselling
during the waiting time before the POCT results could
be read, the DBS EQA method did not cause any delay
as this was done during the 15 minute waiting time.
Shipment and laboratory methodology
The ANC registration forms and DBS samples were col-
lected in March, June and October. Samples were counted
and checked for humidity (changed desiccants if required)
before shipment at ambient temperature to the laboratory.
On average, the time between sampling and arrival at
the laboratory where testing took place was 95 days
(minimum = 62 days, maximum = 142 days). The DBS
samples were transported at ambient temperature to
the Leiden Cytology and Pathology Laboratory, Leiden,
The Netherlands where the samples were tested. Upon
arrival at the laboratory, the quality of DBS samples
were reviewed and recorded according to the online
protocol [7]. The DBS quality data was entered into
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epi-info. The DBS were placed with new desiccants in a
ziplock bag and stored at 4°C until tested. To allow fast
interpretation of the results, an excel file was developed
that imports Epi-info data. The Excel file automatically
presents data from each clinic graphically which could
aid supervisors to adequately identify and provide detailed
feedback to clinics requiring supervision when the
EQA method is implemented. All documents are
freely available online [7].
Syphilis testing with DBS samples
Treponema pallidum Particle Agglutination assay (TPPA,
Serodia, Tokio, Japan) was performed as described previ-
ously [5]. Briefly, 6 mm spots were punched with a DBS
puncher (PerkinElmer, Greenville, SC, USA) in a 96 flat
well plate. 100 μl Phosphate buffer Saline (PBS) with 0.05%
tween20 was added, shaken for 2 minutes and eluted over-
night at 4°C. DBS eluates were shaken for 2min and 25 μl
was transferred to a clean 96 U well plate. 25 μl specimen
diluent was added, mixed thoroughly and 25 μl was
transferred to a second column. 25 μl sensitized or un-
sensitized particles were added and agglutination was
read after 2 hours incubation. Results were read indepen-
dently by two technicians.
HIV testing with DBS samples
An Enzyme Immunoassay (EIA,) Vironostika HIV EIA
(Biomerieux, France), was used to review the HIV POCT
results. The EIA was performed as described by the
US Centers for Disease Control and Prevention (CDC)
(Vironostika protocol) [8].
Proficiency panel results
For quality assurance purposes, various measures were
taken at clinic level. With every new syphilis POCT lot,
a known positive and negative was tested at the clinic.
Additionally, syphilis proficiency panels were made and
regularly brought to clinics to assess the HCW per-
formance. The syphilis proficiency panels consisted of
four dried tubes samples (DTS) as described previously
[9]. Briefly, DTS samples were made in the laboratory
by drying aliquots of known positive and negative sera
in small tubes and panels were sent to the clinics. The
proficiency panels were sent to the clinics from July
2010 till January 2011 every month. The proficiency
panels consisted of four dried tube specimens with
known serostatus and changing number of positive and
negative samples. At the clinic, HCWs reconstituted
the DTS with PBS-tween20 buffer and the reconstituted
serum was used to test with syphilis POCT. Results were
recorded and sent back to the laboratory.
Statistical analysis
Double data entry into Epi-info 3.5.3 (CDC, Atlanta,
USA) was applied and data was analysed in Stata12
(Stata Corp, Texas, USA). The use of DBS for HIV or
syphilis testing is not the gold standard methodology,
However, for the analysis, DBS based tests were used as
reference method and, to improve simplicity and read-
ability of the manuscript, we use the terms sensitivity
and specificity for syphilis and HIV POCT results, instead
of positive and negative concordance between the two
testing methodologies.
Results
DBS as EQA method
To evaluate the implementation of the EQA method
across the ten antenatal care clinics (ANC), the quality
of DBS samples was reviewed. In total, 2,341 samples
were collected. Of these samples, 140 samples (6.07%)
were excluded due to invalid syphilis POCT (60 samples)
or TPPA test result (e.g. indeterminate test or test
could not be performed) (64 samples), missing forms
(10 samples), or the DBS sample was unusable (6 samples),
either because of fungal growth or because it did not
contain enough blood to obtain at least one 6 mm
punch. Of the remaining 2,201 cards, containing 11,005
spots, 10,179 (92.5%) were correctly spotted. Of the
7.5% incorrect spots, 356 spots (3.2%) were empty.
The quality of testing at Tanzanian clinics
HIV and syphilis tests are routinely performed as part of
the ANC services provided to pregnant women visiting
these clinics. Due to a prolonged stock-out of HIV
POCT during the study period, many women (55.8%)
were not screened for HIV while still receiving a syphilis
test. Out of the 2201 samples included in this study, 972
(44.1%) had recorded HIV test results and 966 (99.5%)
were concordant between POCT and DBS. In total, 42
patients (4.3%) were identified as positive by SD Bioline
HIV POCT of which 29 were retested by Determine
HIV POCT as part of the national testing algorithm. All
Determine tests confirmed HIV positivity. It is unclear
whether the 13 positives not confirmed by a second
POCT (Determine) were identified as HIV positive or
negative and they were therefore excluded from further
analysis. Of the 29 positive samples, 28 (97%) were positive
by DBS tests and 1 was negative. 929 (99.7%) samples
were HIV POCT negative of which 3 (0.3%) were positive
by DBS tests (Table 1).
Out of 2,201 DBS samples collected, 189 (8.6%) were
positive by syphilis POCT and 202 (9.2%) were positive
by DBS TPPA. In total, 2012 samples were negative by
syphilis POCT and 1999 were negative for DBS TPPA
(Table 1). Using DBS TPPA as the reference method, the
sensitivity of syphilis tests varied between clinics, with a
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median of 70% and 25th and 75th quartile of 61-79%. The
specificity was consistent, with a median of 96% and 25th
and 75th quartiles of 95-98% (Figure 1).
No remedial training for POCT testing or DBS collec-
tion was given during the study period. To evaluate the
performance of the clinics over time, January and August,
the months when the largest number of samples was
collected, were compared. In January 94.5% and in
August 96.7% of the samples were concordant between
both methods. This finding suggests that the clinics did
not perform differently at the beginning or at the end
of the study.
Proficiency panel results
To evaluate the performance of the DBS EQA method
to detect underperforming clinics, we compared our
results with those obtained using syphilis proficiency
panels. All clinics scored 100% during November till
January 2011 based on the proficiency panel (Table 2).
During the 7months when proficiency panels were
performed, clinic 9 scored the poorest with an average
of 64% correct, while obtaining good performance in our
EQA. Clinic 7 scored 79% correct in the proficiency panels
while having a poor performance by our EQA (37.5%).
The proficiency panel results did not correlate well
with the results found by our EQA method.
Discussion
In this study, DBS proved useful as an EQA method for
syphilis and HIV POCT to monitor the quality of testing
performed by HCW as part of routine ANC services in
Tanzania. Based on our results, the quality of testing
varied between the ten clinics, even though all clinics
used the same syphilis POCT lots. The hospital and
dispensaries seems to be performing better than the
health centres when using DBS as reference method.
These EQA results can be used to identify clinics where
remedial training in the performance of syphilis POCTs
is required.
This study showed the possibility to seamlessly integrate
HIV and syphilis POCT quality assurance, making it
possible to have one EQA method for preventing mother-
to-child transmission of HIV services.
The DBS method has advantages over proficiency
panels as this method gives insight into the quality of
testing during routine patient services. Proficiency panel
samples are tested by HCW with the knowledge that
they are being monitored and only contain four samples.
As only one proficiency panel is sent out to every clinic,
only one HCW is evaluated while with DBS EQA, all
HCWs are included in the EQA procedure. These reasons
could potentially affect the proficiency panel result and
could cause misinterpretation of the actual testing
quality during routine patient services.
Compared to DBS TPPA the overall performance of
the 10 clinics for syphilis POCT was lower than the
manufacturer’s claim, although in agreement with an
earlier evaluation in Tanzania [10]. Additionally, a labora-
tory based evaluation performed in Tanzania suggests
that the syphilis POCT sensitivity was low compared to
TPPA performed on plasma (60%) [11]. The low POCT
performance found in this study should be interpreted
with caution as differentiation cannot be made between
discordant test result and incorrect interpretation or
recording of the results by HCW. Worker turnover
may be one of the reasons for low performance as the
replacement worker may not have been properly
trained. The strength of this study is that the EQA
method can be evaluated continuously under routine
clinical conditions. Because of this, the sample quality can
be influenced by, for example, environmental influences
during incorrect storage at the clinic or inter and national
transportation of the kits.
The EQA method was easily implemented by HCW
under routine conditions. Although 92.5% of the samples
Table 1 Syphilis and HIV POCT results compared to DBS
laboratory based syphilis and HIV tests per clinic,
Mwanza, Tanzania 2011
Syphilis HIV
Clinic POCT DBS POCT DBS
pos neg pos neg
1 Hosp pos 21 12 pos 17 1
neg 13 376 neg 0 254
2 Disp pos 8 7 pos 0 0
neg 1 93 neg 0 13
3 Disp pos 6 3 pos 2 0
neg 1 61 neg 0 42
4 Disp pos 12 7 pos 4 1
neg 3 150 neg 0 67
5 Disp pos 9 5 pos 2 0
neg 3 96 neg 0 13
6 Disp pos 13 6 pos 0 0
neg 12 119 neg 0 24
7 HC pos 9 4 pos 4 1
neg 15 309 neg 1 78
8 HC pos 14 4 pos 8 0
neg 9 231 neg 1 248
9 HC pos 21 5 pos 0 0
neg 6 251 neg 0 25
10 HC pos 17 6 pos 3 0
neg 9 254 neg 0 162
Total pos 130 59 pos 42 3
neg 72 1940 neg 2 926
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collected by the clinics were of good quality, humidity
remained a concern. Humidity control is essential to
preserve antibody and antigens stored on DBS samples
and to prevent growth of mould. Storage of desiccants
at the clinics for several months proved difficult as they
became humid, especially during the rainy season. More
suitable containers with an airtight lid should be used.
Additionally, long term storage (e.g. more than 4
weeks) at clinics should be prevented as this potentially
could lead to loss of samples or increase risks of un-
favourable storage conditions that could lead to degra-
dation of antibodies or antigen [12].
This study had some limitations. Because of the study
design, laboratory tests were performed abroad which
caused a delay in re-testing samples. It is recommended
to perform re-testing at more frequent intervals and in
the same country, as this will most likely be practically
and financially a preferable option. Additionally, it was
not feasible to monitor the costs of this EQA method.
Although the process time in the laboratory was rela-
tively quick, this EQA method can be more costly than,
for example, the use of proficiency panels. By combining
this EQA for multiple infectious diseases as we did for
HIV and syphilis, the economies of scope would limit
the EQA costs compared to setting up two independent
EQA methods.
To use this EQA method in practice, the number of
samples that should be collected per clinic depends on
the settings. The POCT performance (e.g. sensitivity and
specificity), incidence and prevalence of the infectious
disease, robustness of the test outcome, staff turnover,
as well as past EQA results need to be taken into
Table 2 Samples collected per clinic and proficiency panel results per clinic
POCT performed per clinic Proficiency panel results EQA results (DBS)
Clinic Clinic type Number of
HIV tests
Number of
syphilis tests
Last
3 months*
Overall
(7 months)
Sensitivity**
(95% CI)
Specificity**
(95% CI)
1 District referral hospital 272 422 100% 86% 61.8% (43.6-77.8%) 96.9% (94.7-98.4%)
2 Dispensary 13 109 100% 89% 88.9% (51.8-99.7%) 93.0% (86.1-97.1%)
3 Dispensary 45 71 100% 86% 85.7% (42.1-99.6%) 95.3% (86.9-99%)
4 Dispensary 72 172 100% 88% 80.0% (51.9-95.7%) 95.5% (91–98.2%)
5 Dispensary 15 113 100% 90% 75.0% (42.8-94.5%) 95.0% (88.8-98.4%)
6 Dispensary 24 150 100% 93% 52.0% (31.3-72.2%) 95.2% (89.8-98.2%)
7 Health centre 84 337 100% 79% 37.5% (18.8-59.4%) 98.7% (96.8-99.7%)
8 Health centre 257 258 100% 92% 60.9% (38.5-80.3%) 98.3% (95.7-99.5%)
9 Health centre 25 283 100% 64% 77.8% (57.7-91.4%) 98.0% (95.5-99.4%)
10 Health centre 165 286 100% 95% 65.4% (44.3-82.8%) 97.7% (95–99.1%)
Total 972 2201 100% 86% 64.4% (57.3-71%) 97.0% (96.2-97.7%)
*last 3 months of proficiency panel results (November - January 2011).
**sensitivity and specificity of syphilis POCT using DBS TPPA as reference.
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Figure 1 Syphilis POCT results evaluated against DBS as reference method, Mwanza, Tanzania, 2011. The figure provides percentages
based on the total number of samples collected per clinic. Hops = Hospital, Disp = Dispensary, HC = Health centre. Pos = positive, Neg = Negative.
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account in determining the number of samples that are
required to obtain good insight in quality of POCT at
the clinics [13].
Conclusion
To the authors’ knowledge, this is the first paper descri-
bing the implementation of DBS samples as EQA method
for HIV and syphilis POCT. The key findings of our work
suggest the necessity for stringent quality control of
POCT as the quality of testing seem to vary between
clinics. On average, the sensitivity of the POCt, compared
to DBS TPPA was low. The DBS EQA method potentially
provides a better solution to assure the quality of POCT
testing, in comparison to proficiency panels in Africa.
The EQA method evaluated in this study could be easily
rolled out in developing countries to improve and assure
the quality of POCT testing.
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